Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
9
pubmed:dateCreated
1986-10-30
pubmed:abstractText
The growth fractions of 160 mammary carcinomas and 30 benign mammary lesions were determined in situ by immunostaining with the monoclonal antibody Ki-67. Benign lesions had a mean value of 3% Ki-67 positive cells, whereas the mean value of mammary carcinomas was 16.6%. A comparison of the mean values of Ki-67 positive cells with the histological grade of the tumours showed a correlation between these two variables--that is, histological grade 1 showed 9%, grade 2 16%, and grade 3 26% proliferating cells. Considering the individual Ki-67 values in the different histological grades, it was evident that there was considerable scatter in the number of proliferating cells, so that the proliferation rates of grades 1, 2, and 3 overlapped each other. This indicates a dissociation between histological grade of malignancy and size of the growth fraction in most breast cancers. Follow up studies are needed to establish which of the two variables--that is, morphological degree of malignancy, or the proportion of Ki-67 positive cells--correlates better with response to treatment and survival in individual cases.
pubmed:commentsCorrections
http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-1098765, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-13499785, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-476641, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-521499, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-5901409, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-6123647, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-6198355, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-6206131, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-6339421, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-6396192, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-6728713, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-6754630, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-6831353, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-7226045, http://linkedlifedata.com/resource/pubmed/commentcorrection/3020096-7371021
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Sep
pubmed:issn
0021-9746
pubmed:author
pubmed:issnType
Print
pubmed:volume
39
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
977-80
pubmed:dateRevised
2009-11-18
pubmed:meshHeading
pubmed:year
1986
pubmed:articleTitle
Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.
pubmed:publicationType
Journal Article, Research Support, Non-U.S. Gov't